Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance

Sander P.J. Joosten; Marcel Spaargaren; Hans Clevers; Steven T. Pals

doi:10.1016/j.bbcan.2020.188437

Related publications

Article2019

MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance

Sander P.J. Joosten, Tomohiro Mizutani, Marcel Spaargaren, Hans Clevers, Steven T. Pals

Article2014

Hepatocyte Growth Factor Deficiency in COPD

Peter J Barnes

Article2018

Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling

Debanjan Dhar, Laura Antonucci, Hayato Nakagawa, Ju Youn Kim, Elisabeth Glitzner, Stefano Caruso, Shabnam Shalapour, Ling Yang, Mark A. Valasek, Sooyeon Lee, Kerstin Minnich, Ekihiro Seki, Jan Tuckermann, Maria Sibilia, Jessica Zucman‐Rossi, Michael Karin

Article2023

Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance

Nasim Ebrahimi, Maral Afshinpour, Siavash Seifollahy Fakhr, Paniz Ghasempour Kalkhoran, Vida Shadman-Manesh, Samaneh Adelian, Sheida Beiranvand, Fatemeh Rezaei‐Tazangi, Roya Khorram, Michael R Hamblin, Amir Reza Aref

Article2018

Gankyrin Contributes to Tumorigenesis and Chemoresistance in Sporadic Colorectal Cancer

Toshiharu Sakurai, Yoriaki Komeda, Tomoyuki Nagai, Ken Kamata, Kosuke Minaga, Kentarou Yamao, Mamoru Takenaka, Satoru Hagiwara, Tomohiro Watanabe, Naoshi Nishida, Hiroshi Kashida, Kazuhiko Nakagawa, Masatoshi Kudo